Lexaria Bioscience (LEXX) Stock: Buy, Sell, or Hold?
LEXX - Lexaria Bioscience Corp. Common Stock
$3.55
-0.42 (-10.58%)
▼
5d:
-74.91%
30d:
-56.17%
90d:
+477.71%
HOLD
MODERATE Confidence
Analysis Updated: Sep 14, 2026 12:00 AM ET
Earnings: Jul 13, 2026
0d
Get Alerted When LEXX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: LEXX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: LEXX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: LEXX is currently trading at $3.55, which is considered oversold relative to its 30-day fair value range of $6.21 to $12.37.
Technical Outlook: Technically, LEXX is in a strong uptrend. Immediate support is located at $3.14, while resistance sits at $14.37. Short-term momentum is weak, with the stock down 10.6% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $52.50 (+1378.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LEXX is in a strong uptrend. Immediate support is located at $3.14, while resistance sits at $14.37. Short-term momentum is weak, with the stock down 10.6% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $52.50 (+1378.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$6.21 -
$12.37
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-10.6%)
- BULLISH: Trading 1378.9% below Wall St target ($52.50)
- NEUTRAL: Bottoming setup forming (40/100) — watch for confirmation
- CAUTION: 5-day price weakness (-74.9%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$6.21 -
$12.37
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.14
Resistance Level
$14.37
Current Trend
Strong Uptrend
Technical data as of
Sep 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.76
Wall Street Target
$52.50
(+1378.9%)
Revenue Growth (YoY)
-88.5%
Share & Embed Analysis
Last updated: September 15, 2026 7:06 AM ET
Data refreshes hourly during market hours. Next update: 8:06 AM
Data refreshes hourly during market hours. Next update: 8:06 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LEXX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$110 | 58 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$200 | 44 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 46 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$21 | 46 HOLD |
